Bambusa Therapeutics
Drug DiscoveryWebsite
Operator of a biotechnology company intended to create bispecific antibodies for treating immunological and inflammatory disorders. The company specializes in building a diverse portfolio of molecules...
Valuation
$555M
Market implied
Share Price
N/A
Total Raised
$143M
Last Round
Early Stage VC (Series A2)
Oct 2025
Latest Funding Round
Early Stage VC (Series A2)
Oct 31, 2025
$40M
raised
Investors
+11 other investors